Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Scientists Engineer DNA-based Nanotechnology to Stimulate Potent Antitumor Immune Responses in Preclinical Models

The Wistar InstituteSeptember 24, 2020

Tag: melanoma , CD8 T cell , DNA

PharmaSources Customer Service